Published in:
Volume 4 / Year 2015 / Issue 1

Health Canada’s perspective on the clinical development of biosimilars and related scientific and regulatory challenges

Author(s): , ,
Page: 36-41

Abstract: Biologicals have offered a new avenue for targeting therapy to treat life-threatening and chronic diseases. The recent or pending patent expirations of many successful biologicals have permitted the marketing… Read More »

Go Back Print